Cargando…
Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways
Schizophrenia is a severe and disabling psychiatric disorder with a complex and multifactorial etiology. The lack of consensus regarding the multifaceted dysfunction of this ailment has increased the need to explore new research lines. This research makes use of proteomics data to discover possible...
Autores principales: | Rodrigues-Amorim, Daniela, Rivera-Baltanás, Tania, Vallejo-Curto, María del Carmen, Rodriguez-Jamardo, Cynthia, de las Heras, Elena, Barreiro-Villar, Carolina, Blanco-Formoso, María, Fernández-Palleiro, Patricia, Álvarez-Ariza, María, López, Marta, García-Caballero, Alejandro, Olivares, José Manuel, Spuch, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897280/ https://www.ncbi.nlm.nih.gov/pubmed/31849731 http://dx.doi.org/10.3389/fpsyt.2019.00885 |
Ejemplares similares
-
Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020) -
The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2021) -
Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System
por: Freiría-Martínez, Luis, et al.
Publicado: (2023) -
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020) -
Using psychoneuroimmunity against COVID-19
por: Kim, Sung-Wan, et al.
Publicado: (2020)